These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 8294111)

  • 1. Transgenic mouse models of hepatocellular carcinoma.
    Gordon JW
    Hepatology; 1994 Feb; 19(2):538-9. PubMed ID: 8294111
    [No Abstract]   [Full Text] [Related]  

  • 2. Hepatocarcinogenesis is the sequel to hepatitis in Z#2 alpha 1-antitrypsin transgenic mice: histopathological and DNA ploidy studies.
    Geller SA; Nichols WS; Kim S; Tolmachoff T; Lee S; Dycaico MJ; Felts K; Sorge JA
    Hepatology; 1994 Feb; 19(2):389-97. PubMed ID: 8294096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analyses of hepatocellular proliferation in a mouse model of alpha-1-antitrypsin deficiency.
    Rudnick DA; Liao Y; An JK; Muglia LJ; Perlmutter DH; Teckman JH
    Hepatology; 2004 Apr; 39(4):1048-55. PubMed ID: 15057909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathogenesis of chronic liver injury and hepatocellular carcinoma in alpha-1-antitrypsin deficiency.
    Perlmutter DH
    Pediatr Res; 2006 Aug; 60(2):233-8. PubMed ID: 16864711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Iron, HCV, and liver cancer: hard metal setting the pace?
    Mueller S; Afdhal NH; Schuppan D
    Gastroenterology; 2006 Jun; 130(7):2229-34. PubMed ID: 16762645
    [No Abstract]   [Full Text] [Related]  

  • 6. [Liver and hereditary alpha 1-antitrypsin deficiency].
    Feldmann G
    Gastroenterol Clin Biol; 1993; 17(2):83-93. PubMed ID: 8388836
    [No Abstract]   [Full Text] [Related]  

  • 7. Hepatocarcinogenesis: a dynamic cellular perspective.
    Farber E; Sarma DS
    Lab Invest; 1987 Jan; 56(1):4-22. PubMed ID: 3025514
    [No Abstract]   [Full Text] [Related]  

  • 8. Indomethacin increases liver damage in a murine model of liver injury from alpha-1-antitrypsin deficiency.
    Rudnick DA; Shikapwashya O; Blomenkamp K; Teckman JH
    Hepatology; 2006 Oct; 44(4):976-82. PubMed ID: 17006946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alpha-1-antitrypsin deficiency and liver disease.
    Millward-Sadler GH
    Acta Med Port; 1981; (Suppl 2):91-102. PubMed ID: 6263065
    [No Abstract]   [Full Text] [Related]  

  • 10. Hepatocellular carcinoma in a 12-year-old child with PiZZ alpha1-antitrypsin deficiency.
    Hadzic N; Quaglia A; Mieli-Vergani G
    Hepatology; 2006 Jan; 43(1):194. PubMed ID: 16374862
    [No Abstract]   [Full Text] [Related]  

  • 11. Human and mouse hepatocellular adenoma and carcinoma display similar tumorigenesis pathway alterations.
    Zucman-Rossi J
    J Hepatol; 2008 May; 48(5):884-6. PubMed ID: 18314218
    [No Abstract]   [Full Text] [Related]  

  • 12. Synergy between transforming growth factor alpha and hepatitis B virus surface antigen in hepatocellular proliferation and carcinogenesis.
    Jakubczak JL; Chisari FV; Merlino G
    Cancer Res; 1997 Aug; 57(16):3606-11. PubMed ID: 9270035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Primary liver cell carcinoma as complication of alpha 1-antitrypsin deficiency in a 67 year old man].
    van den Hazel SJ; Meijer JW; van den Elshout FJ; de Vries RA
    Ned Tijdschr Geneeskd; 2000 Nov; 144(47):2269-72. PubMed ID: 11109473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gastrointestinal aspects of alpha 1-antitrypsin deficiency.
    Braxel C; Versieck J; Barbier F
    Acta Gastroenterol Belg; 1980; 43(11-12):451-63. PubMed ID: 6259867
    [No Abstract]   [Full Text] [Related]  

  • 15. Alpha-1-antitrypsin deficiency and liver disease.
    Propst T; Propst A; Dietze O; Judmaier G; Braunsteiner H; Vogel W
    Dig Dis; 1994; 12(3):139-49. PubMed ID: 7988061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hepatocellular carcinoma in patients with metabolic liver disease].
    Takeuchi Y; Sugimoto M
    Nihon Rinsho; 2001 Oct; 59 Suppl 6():469-73. PubMed ID: 11761995
    [No Abstract]   [Full Text] [Related]  

  • 17. Hepatic iron overload induces hepatocellular carcinoma in transgenic mice expressing the hepatitis C virus polyprotein.
    Furutani T; Hino K; Okuda M; Gondo T; Nishina S; Kitase A; Korenaga M; Xiao SY; Weinman SA; Lemon SM; Sakaida I; Okita K
    Gastroenterology; 2006 Jun; 130(7):2087-98. PubMed ID: 16762631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. alpha 1-antitrypsin phenotype PiMZ, a risk factor for liver cirrhosis but not for liver cancers in Thailand.
    Smanadhikorn P; Pongpaew P; Srivatanakul P; Tungtrongchitr R; Supanaranond W; Schelp FP; Migasena P
    Southeast Asian J Trop Med Public Health; 1995 Jun; 26(2):240-2. PubMed ID: 8629052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [T cell response to hepatitis B and C: from viral elimination to hepatocellular carcinoma].
    Thimme R; Spangenberg HC; Von Weizsäcker F; Blum HE
    Dtsch Med Wochenschr; 2002 Oct; 127(43):2277-9. PubMed ID: 12397543
    [No Abstract]   [Full Text] [Related]  

  • 20. Mitochondrial autophagy and injury in the liver in alpha 1-antitrypsin deficiency.
    Teckman JH; An JK; Blomenkamp K; Schmidt B; Perlmutter D
    Am J Physiol Gastrointest Liver Physiol; 2004 May; 286(5):G851-62. PubMed ID: 14684378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.